Figure 3
![Figure 3](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2F1471-2407-13-49/MediaObjects/12885_2012_Article_3736_Fig3_HTML.jpg)
Impact of EREG mRNA levels on cetuximab-treated patient survival by KRAS tumour mutation. (Blue line: EREG-high, Red line: EREG-low).a) KRAS wild type (p=0.011), b) KRAS mutated (p=0.022).
Impact of EREG mRNA levels on cetuximab-treated patient survival by KRAS tumour mutation. (Blue line: EREG-high, Red line: EREG-low).a) KRAS wild type (p=0.011), b) KRAS mutated (p=0.022).